{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:59:35Z","timestamp":1787605175840,"version":"build-2736575974"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Isr J Health Policy Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n                <jats:title>Abstract<\/jats:title>\n                <jats:p>The leading formal drug policy in Israel is the traditional approach of abstinence, probation, and punitive measures based on three main pillars: Enforcement, Treatment and Rehabilitation, and Prevention. However, under the treatment pillar, Israel has adopted a number of harm reduction services, focused mostly on people who use heroin and people who inject drugs. These include Methadone Maintenance Treatment, Buprenorphine Maintenance Treatment, and Needle and Syringe Exchange Programs. More specialized services are designated mostly for people who use drugs, who frequent the largest open drug scene in Tel-Aviv. These include a health clinic, an emergency apartment for female addict sex-workers, and a \u2018First Step\u2019 center. Even so, the harm reduction approach has remained controversial, stigmatized, and is considered a sub-category for total-abstinence treatment in Israel. This paper follows the evolution of harm reduction interventions in Israel among people who use drugs and sheds light on the lack of a comprehensive, well-planned, formal national harm reduction drug policy. Additionally, this article expresses concern over the uncertain future of Israel\u2019s comprehensive and balanced drug treatment policies caused by the structural changes in abolishing the Israel Anti-Drug Authority, the statutory authority and central body in Israel that promoted and coordinated all national policies related to treatment and harm reduction.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Although it is a major challenge to translate worldwide evidence and research findings into action and social change, recommendations are offered to implement a comprehensive harm reduction drug policy led by a multidisciplinary group of policy-makers across all areas of drug policy. These focus on expanding and developing more services for Opioid Maintenance Therapy patients and people who inject drugs as well as a national effort to reduce high levels of stigma and discrimination against them, encompassing other common substances and focusing on populations such as adolescents and young adults that engage in other types of substance use such as cannabis, amphetamine-type stimulants, and hallucinogens.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13584-019-0343-3","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T13:09:37Z","timestamp":1571231377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5092-520X","authenticated-orcid":false,"given":"Hagit","family":"Bonny-Noach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"343_CR1","volume-title":"Psychoactive drug use among the adult population in Israel- national epidemiological survey","author":"Y Ezrachi","year":"2017","unstructured":"Ezrachi Y, Dayan Y, Rosiner I, Harel-Fisch Y. Psychoactive drug use among the adult population in Israel- national epidemiological survey. Jerusalem: Israel Anti-Drug Authority; 2017. (In Hebrew)"},{"key":"343_CR2","unstructured":"Harel-Fisch Y, Hizi S, Yogev I, & Zadok Y. Israel-Drug situation and policy. Pompidou Group of the Council of Europe, 21. 2014. Retrieved June 2018 from: \n                    https:\/\/rm.coe.int\/drug-situation-and-policy-by-yossi-harel-fisch-sonia-hizi-iris-yogev-a\/168075f0e0"},{"key":"343_CR3","unstructured":"IADA-web, 2018. (In Hebrew). Retrieved June 2018 from: \n                    http:\/\/www.antidrugs.org.il\/english\/template\/default.aspx?catid=248"},{"key":"343_CR4","unstructured":"Global State of Harm Reduction 2016 - Middle East and North Africa. Harm Reduction International. Retrieved June 2018 from: \n                    https:\/\/www.hri.global\/files\/2017\/06\/26\/A3_poster_hri2016_web.pdf"},{"key":"343_CR5","unstructured":"Chemtob D. HIV HIV\/AIDS in Israel: Periodic Epidemiological Report 1981\u20132017. Ministry of Health Public Health Services Division of Epidemiology Department of Tuberculosis & AIDS Jerusalem.2014. (In Hebrew-Abstract in English). Retrieved December 2018 from: \n                    https:\/\/www.health.gov.il\/PublicationsFiles\/AIDS_PeriodicReport2018e.pdf"},{"key":"343_CR6","unstructured":"MOH. Annual Report -Department for the Treatment of Substances Use- Ministry of Health .2017. (In Hebrew). Retrieved June 2018 from: \n                    https:\/\/www.health.gov.il\/UnitsOffice\/HD\/MHealth\/mental\/addictions\/Documents\/mtl-addictions-2017.pdf"},{"key":"343_CR7","unstructured":"Bonny-Noach H, & Toys S. S09\u20133: Injecting drug use, sex work and differential harm reduction approaches for women: Ethnographic study in Israel's largest open drug scene. Heroin Addiction and Related Clinical Problems, 20, 43. 2018."},{"issue":"4","key":"343_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/0022042618791261","volume":"48","author":"H Bonny-Noach","year":"2018","unstructured":"Bonny-Noach H, Ronel N. Everyday Substance Insecurity among homeless injection drug users in Israel\u2019s largest open drug scene. J Drug Issues. 2018;48(4):645\u201356.","journal-title":"J Drug Issues"},{"key":"343_CR9","first-page":"43","volume":"20","author":"H Mell","year":"2018","unstructured":"Mell H. S09-2: HIV outbreak related to injection of new psychoactive substances in Tel Aviv, Israel. Heroin Addiction and Related Clinical Problems. 2018;20:43.","journal-title":"Heroin Addiction and Related Clinical Problems"},{"key":"343_CR10","unstructured":"EMCDDA - European Monitoring Centre for Drugs and Drug Addiction .2017. Retrieved June 2018 from: \n                    http:\/\/www.emcdda.europa.eu\/policy-and-law"},{"key":"343_CR11","unstructured":"UN. Single convention on narcotic drugs.1961. Retrieved June 2018 from: \n                    http:\/\/www.unodc.org\/pdf\/convention_1961_en.pdf"},{"key":"343_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugpo.2016.12.014","volume":"60","author":"J Collins","year":"2018","unstructured":"Collins J. Rethinking \u2018flexibilities\u2019 in the international drug control system\u2014potential, precedents and models for reforms. Int J Drug Policy. 2018;60:107\u201314.","journal-title":"Int J Drug Policy"},{"issue":"10026","key":"343_CR13","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(16)00619-X","volume":"387","author":"J Csete","year":"2016","unstructured":"Csete J, Kamarulzaman A, Kazatchkine M, Altice F, Balicki M, Buxton J, Hart C. Public health and international drug policy. Lancet. 2016;387(10026):1427\u201380.","journal-title":"Lancet"},{"key":"343_CR14","unstructured":"Gray J. Why our drug laws have failed: a judicial indictment of war on drugs. Temple University Press2010."},{"issue":"1","key":"343_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/0887403403255315","volume":"15","author":"EL Jensen","year":"2004","unstructured":"Jensen EL, Gerber J, Mosher C. Social consequences of the war on drugs: the legacy of failed policy. Criminal Justice Policy Review. 2004;15(1):100\u201321.","journal-title":"Criminal Justice Policy Review"},{"issue":"5","key":"343_CR16","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/add.14484","volume":"114","author":"SE Wakeman","year":"2019","unstructured":"Wakeman SE. Policies that Punish the Powerless\u2019 in a supply-led illicit fentanyl market. Addiction. 2019;114(5):781\u20132.","journal-title":"Addiction"},{"key":"343_CR17","unstructured":"Reiter M. Treatment of drug victims in Israel. In D. Green, Ed. Drugs-facts, questions and problems. (p. 375\u2013405). Ministry of Defense, Israel 1995.(In Hebrew)."},{"key":"343_CR18","unstructured":"Gleser J, Elisha D, Reiter M, Margolis A. Department for the treatment of substance abuse, Israel Ministry of Health: Responsibility and services. In: Isralowitz R, Afifi M, Rawson R, editors. Drug problems: Cross-Cultural policy and program development: Greenwood Publishing Group; 2002. p. 263\u20135."},{"key":"343_CR19","unstructured":"Caspi J. Dangerous drugs: policy, control, enforcement and trial. Haifa: Tamar.1995."},{"issue":"1","key":"343_CR20","first-page":"20","volume":"2","author":"P Rosca","year":"2015","unstructured":"Rosca P, Grinshpoon A, Goldman K, Margolis A, Ponizovsky AM. The Israeli National Substance Abuse Treatment Registry (INSATR): a review of the registry-based research findings and future implications. Front Clin Med. 2015;2(1):20\u20137.","journal-title":"Front Clin Med"},{"key":"343_CR21","unstructured":"Levit S, Ben-Levi E, & Gelkopf M. Methadone and agonists treatment. In M. Hovav Ed. treatment and rehabilitation of drug abusers in Israel - development, current status and issues. (p. 75\u201388). Tel-Aviv: Tcherikover.2002. (In Hebrew)."},{"key":"343_CR22","unstructured":"Ben-Yehuda N. Moral panics: sociological perspective. In: D. Green (Ed). Drugs-facts, questions and problems. (p- 187-210). Ministry of Defense, Israel1995."},{"key":"343_CR23","unstructured":"Inbar A. The medical treatment of drug addiction in Israel-a report submitted to the special committee on drug and alcohol abuse. Knesset, Research and Information Center. 2015. Retrieved June 2018 from: \n                    https:\/\/fs.knesset.gov.il\/globaldocs\/MMM\/111307dc-1277-e511-80d1-00155d0ad6b2\/2_111307dc-1277-e511-80d1-00155d0ad6b2_11_6894.pdf"},{"key":"343_CR24","unstructured":"Levit S, & Shif M. Structured difficulties in the treatment of drug addicts in Israel . In: Hovav, M., Mahel, H. & Golan, M. (eds.). Addictions, Violence and Sex Crimes \u2013 Treatment in View of the Law. (p. 79\u201392). Jerusalem: Carmel.2008."},{"key":"343_CR25","unstructured":"Gal S. Israel Anti-Drug Authority: Responsibility and services. In R. Isralowitz, M. Afifi & R. Rawson (Eds), Drug problems: Cross-Cultural Policy and Program Development (pp. 276\u2013278). Greenwood Publishing Group.2002."},{"key":"343_CR26","unstructured":"Lewental E. Treatment of health services for drug victims . In M. Hovav Ed. Treatment and Rehabilitation of Drug Abusers in Israel - Development, Current Status and Issues. (p. 61\u201373). Tel-Aviv: Tcherikover.2002. (In Hebrew)."},{"issue":"1","key":"343_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13584-018-0223-2","volume":"7","author":"H Bonny-Noach","year":"2018","unstructured":"Bonny-Noach H. The evolution of Israeli public policy for drug-using backpackers. Isr J Health Policy Res. 2018;7(1):23. \n                    https:\/\/doi.org\/10.1186\/s13584-018-0223-2\n                    \n                  .","journal-title":"Isr J Health Policy Res"},{"key":"343_CR28","unstructured":"Harm Reduction International-web. 2018. Retrieved June 2018 from: \n                    https:\/\/www.hri.global\/what-is-harm-reduction"},{"issue":"2\u20133","key":"343_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/10826080601141990","volume":"42","author":"S Einstein","year":"2007","unstructured":"Einstein S. Harm and risk reduction: history, theories, issues, and implications. Substance Use Misuse. 2007;42(2\u20133):257\u201365.","journal-title":"Substance Use Misuse"},{"issue":"3","key":"343_CR30","first-page":"175","volume":"51","author":"S Lev-Ran","year":"2014","unstructured":"Lev-Ran S, Nitzan U, Fennig S. Examining the ethical boundaries of harm reduction: from addictions to general psychiatry. Isr J Psychiatry Relat Sci. 2014;51(3):175\u201380.","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"343_CR31","unstructured":"IDPC \u2013 International Drug Policy Consortium. Drug policy guide, 3rd Edition.2006. Retrieved June 2018 from: \n                    http:\/\/fileserver.idpc.net\/library\/IDPC-drug-policy-guide_3-edition_FINAL.pdf"},{"issue":"6","key":"343_CR32","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.drugpo.2009.02.011","volume":"20","author":"M Jourdan","year":"2009","unstructured":"Jourdan M. Casting light on harm reduction: Introducing two instruments for analysing contradictions between harm reduction and \u2018Non-harm reduction\u2019. Int J Drug Policy. 2009;20(6):514\u201320.","journal-title":"Int J Drug Policy"},{"key":"343_CR33","unstructured":"WHO, UNODC, UNAIDS. Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users.2009. Retrieved June 2018 from: \n                    http:\/\/www.unaids.org\/sites\/default\/files\/sub_landing\/idu_target_setting_guide_en.pdf"},{"key":"343_CR34","unstructured":"EMCDDA \u2013 Monographs. D. Hedrich & T. Rhodes (Eds.). Harm reduction: evidence, impacts and challenges.2010. Retrieved June 2018 from: \n                    http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/555\/EMCDDA-monograph10-harm_reduction_final_205049.pdf\n                    \n                  ."},{"key":"343_CR35","volume-title":"Treatment of addicts for hard drugs and alcohol in Israel","author":"G Natan","year":"2011","unstructured":"Natan G. Treatment of addicts for hard drugs and alcohol in Israel. Research and Information Center: Knesset; 2011. Retrieved June 2018 from: \n                    https:\/\/fs.knesset.gov.il\/globaldocs\/MMM\/31576b58-e9f7-e411-80c8-00155d010977\/2_31576b58-e9f7-e411-80c8-00155d010977_11_7383.pdf"},{"key":"343_CR36","unstructured":"Global State of Harm Reduction 2018. Harm Reduction International. Retrieved December 2018 from: \n                    https:\/\/www.hri.global\/files\/2018\/12\/11\/global-state-harm-reduction-2018.pdf"},{"key":"343_CR37","unstructured":"IADA, MOH and MOLSA , Information booklet of Drug and Alcohol Addiction Services .2011."},{"key":"343_CR38","unstructured":"MOH. The Health Ministry's Department for the Treatment of Substance Abuse's Policy Regarding: Treating Opiate Addicts with Medication for an Extended Period of Time (using agonist or partial agonist drugs, e.g. methadone, buprenorphine)- Ministry of Health.2010. Retrieved June 2018 from: \n                    https:\/\/www.health.gov.il\/PublicationsFiles\/Mental_policy_1_english.pdf"},{"issue":"4","key":"343_CR39","first-page":"281","volume":"51","author":"L Goren","year":"2014","unstructured":"Goren L, Carmel Z, Marchevsky S. Buprenorphine for opiate dependence: clinic based therapy in Israel. Isr J Psychiatry Relat Sci. 2014;51(4):281.","journal-title":"Isr J Psychiatry Relat Sci"},{"issue":"1","key":"343_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1300\/J069v25n01_07","volume":"25","author":"E Peles","year":"2006","unstructured":"Peles E, Kreek MJ, Kellogg S, Adelson M. High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. J Addict Dis. 2006;25(1):43\u201350.","journal-title":"J Addict Dis"},{"key":"343_CR41","unstructured":"WHO, UNODC, UNAIDS. Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users.2009. Retrieved June 2018 from: \n                    http:\/\/www.unaids.org\/sites\/default\/files\/sub_landing\/idu_target_setting_guide_en.pdf"},{"key":"343_CR42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2017.11.034","volume":"185","author":"E Peles","year":"2018","unstructured":"Peles E, Schreiber S, Sason A, Adelson M. Similarities and changes between 15-and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) center. Drug Alcohol Depend. 2018;185:112\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"343_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/10550887.2016.1235404","volume":"36","author":"L Shidlansik","year":"2017","unstructured":"Shidlansik L, Adelson M, Peles E. Knowledge and stigma regarding methadone maintenance treatment among personnel of methadone maintenance treatment and non-methadone maintenance treatment addiction facilities in Israel. J Addict Dis. 2017;36(1):30\u20137.","journal-title":"J Addict Dis"},{"issue":"7","key":"343_CR44","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1177\/0306624X10382570","volume":"55","author":"N Ronel","year":"2011","unstructured":"Ronel N, Gueta K, Abramsohn Y, Caspi N, Adelson M. Can a 12-step program work in methadone maintenance treatment? Int J Offender Ther Comp Criminol. 2011;55(7):1135\u201353.","journal-title":"Int J Offender Ther Comp Criminol"},{"key":"343_CR45","unstructured":"Rosca P, & Grinshpoon A. Treatment of buprenorphine among opiate addicts. In: Hovav, M., Mahel, H. & Golan, M. (eds.). Addictions, violence and sex crimes \u2013 treatment in view of the law. (p. 36\u201346). Jerusalem: Carmel.2008."},{"key":"343_CR46","unstructured":"MOH. Annual Summary of the Department of Addiction Treatment - Ministry of Health.2013. (In Hebrew). Retrieved June 2018 from: \n                    https:\/\/www.health.gov.il\/UnitsOffice\/HD\/MHealth\/mental\/addictions\/Documents\/mtl-addictions-2013.pdf"},{"key":"343_CR47","unstructured":"MOH. The Policy of the Department of Addiction Treatment - Ministry of Health, maintains medication treatment and psychosocial therapy for opiate substance addicts (through agonistic or partial agonist drugs such as methadone, buprenorphine \/ buprenorphine \/ naloxone). 2014. (In Hebrew). Retrieved June 2018 from: \n                    https:\/\/www.health.gov.il\/PublicationsFiles\/MTL_Opiates_Policy.pdf"},{"issue":"1\u20132","key":"343_CR48","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3109\/10826080902873010","volume":"45","author":"AM Ponizovsky","year":"2010","unstructured":"Ponizovsky AM, Margolis A, Heled L, Rosca P, Radomislensky I, Grinshpoon A. Improved quality of life, clinical, and psychosocial outcomes among heroin-dependent patients on ambulatory buprenorphine maintenance. Substance Use Misuse. 2010;45(1\u20132):288\u2013313.","journal-title":"Substance Use Misuse"},{"key":"343_CR49","unstructured":"MOH. Annual Report -Department for the Treatment of Substances Use Ministry of Health, 2016. (In Hebrew). Retrieved June 2018 from: \n                    https:\/\/www.health.gov.il\/UnitsOffice\/HD\/MHealth\/mental\/addictions\/Documents\/mtl-addictions-2016.pdf"},{"key":"343_CR50","unstructured":"IADA, MOH and MOLSA, information booklet of drug and alcohol addiction services 2015. Retrieved June 2018 from: \n                    https:\/\/www.health.gov.il\/PublicationsFiles\/meidaon2015.pdf"},{"key":"343_CR51","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Network of outpatient treatment facilities- 2015. Retrieved June 2018 from: \n                    http:\/\/www.emcdda.europa.eu\/countries\/israel_en#pdu\n                    \n                  ."},{"key":"343_CR52","unstructured":"Chemtob D. HIV\/AIDS in Israel, Periodic Report 1980\u20136\/2003. Ministry of Health Public Health Services Division of Epidemiology Department of Tuberculosis & AIDS Jerusalem.2003. (In Hebrew-Abstract in English). Retrieved June 2018 from: \n                    https:\/\/www.health.gov.il\/PublicationsFiles\/AIDS_PeriodicReport2003.pdf"},{"key":"343_CR53","unstructured":"Chemtob D. HIV\/AIDS in Israel: Periodic Epidemiological Report 1981\u20132011. Ministry of Health Public Health Services Division of Epidemiology Department of Tuberculosis & AIDS Jerusalem.2012. (In Hebrew-Abstract in English). Retrieved June 2018 from: \n                    https:\/\/www.health.gov.il\/PublicationsFiles\/AIDS_PeriodicReport2012.pdf.pdf"},{"key":"343_CR54","doi-asserted-by":"crossref","unstructured":"Isralowitz R E. Toward an understanding of Russian-speaking heroin addicts and drug treatment services in Israel. J Soc Work Prac Addictions, 1(2), 33\u201344.2001.","DOI":"10.1300\/J160v01n02_04"},{"key":"343_CR55","unstructured":"IADA, Annual report. 2002. Jerusalem: IADA. (In Hebrew)."},{"key":"343_CR56","unstructured":"IADA, Annual report. 2003. (In Hebrew). Retrieved June 2018 from: \n                    http:\/\/www.antidrugs.org.il\/template\/default.aspx?catid=32"},{"key":"343_CR57","unstructured":"Chemtob D. HIV\/AIDS in Israel, Epidemiological Periodic Report 1981\u20132005. Ministry of Health Public Health Services Division of Epidemiology Department of Tuberculosis & AIDS Jerusalem.2006. (In Hebrew-Abstract in English). Retrieved June 2018 from: \n                    https:\/\/www.health.gov.il\/PublicationsFiles\/AIDS_PeriodicReport2006.pdf"},{"key":"343_CR58","unstructured":"Yizhar-web. 2018. (In Hebrew). Retrieved June 2018 from: \n                    https:\/\/www.izharproject.org.il\/"},{"key":"343_CR59","unstructured":"Chemtob D, Levin Y, Haddad E, Harel N. The National Syringe Exchange Program amongst Intravenous Drug Users in Israel \u2013 A quantitative and qualitative evaluation, 2004\u20132009. Report to the Israel Anti-Drug Authority, Jerusalem.2015. (in Hebrew, Abstract in English)."},{"key":"343_CR60","unstructured":"UNAIDS. Country progress report 2016- Israel.2016. Retrieved June 2018 from: \n                    http:\/\/www.unaids.org\/en\/regionscountries\/countries\/israel\/"},{"key":"343_CR61","unstructured":"Chemtob D. HIV\/AIDS in Israel: Periodic Epidemiological Report 1981\u20132013. Ministry of Health Public Health Services Division of Epidemiology Department of Tuberculosis & AIDS Jerusalem.2014. (In Hebrew-Abstract in English). Retrieved June 2018 from: \n                    https:\/\/www.health.gov.il\/PublicationsFiles\/AIDS_PeriodicReport2014.pdf"},{"key":"343_CR62","unstructured":"Chemtob D. HIV HIV\/AIDS in Israel: Periodic Epidemiological Report 1981-2016. Ministry of Health Public Health Services Division of Epidemiology Department of Tuberculosis & AIDS Jerusalem2017. Retrieved June 2018 from: \n                    https:\/\/www.health.gov.il\/PublicationsFiles\/AIDS_PeriodicReport2017e.pdf"},{"issue":"6\u20137","key":"343_CR63","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/10826080600669579","volume":"41","author":"A Wodak","year":"2006","unstructured":"Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Substance Use Misuse. 2006;41(6\u20137):777\u2013813.","journal-title":"Substance Use Misuse"},{"issue":"3","key":"343_CR64","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000259053","volume":"1","author":"R Bless","year":"1995","unstructured":"Bless R, Korf DJ, Freeman M. Open drug scenes: A cross-national comparison of concepts and urban strategies. European Addiction Research. 1995;1(3):128\u201338.","journal-title":"European Addiction Research"},{"key":"343_CR65","unstructured":"Mell H, Levi A, Levitt S, & Chemtob D. \"wounded are not left in the field\": systemic dealing with addicts homeless. In: H. Mell, M. Hovav., & M. Golan (Eds). Addiction, violence and sexual offense- mandatory treatment. ( p-165-173). Jerusalem: Carmel.2008. (In Hebrew)."},{"key":"343_CR66","unstructured":"Ezra SB. S09-1: \"a thousand-mile journey begins with one step\" - a \"first step\" for drug and alcohol addicts. Heroin Addiction and Related Clinical Problems, 20, 42.2018."},{"key":"343_CR67","unstructured":"Harel-Fisch Y. The evolution of an integrated and coherent policy on drugs and alcohol in Israel (In: R. Muscat, B. Pike (Ed.). Reflections on the concept of coherency for a policy on psychoactive substances and beyond. (p-65-74). Pompidou Group.2012. Retrieved June 2018 from: \n                    https:\/\/rm.coe.int\/reflections-on-the-concept-of-coherency-for-a-policy-on-psychoactive-s\/168075ba74"},{"key":"343_CR68","doi-asserted-by":"crossref","unstructured":"Bonny-Noach H, Sagiv-Alayoff M. Rescuing Israeli travelers: effects of substance abuse, mental health, geographic region of rescue, gender and age of rescuees. J Travel Med. 2017;24(5).","DOI":"10.1093\/jtm\/tax045"},{"key":"343_CR69","doi-asserted-by":"crossref","unstructured":"Bonny-Noach H, Mell H. A drug treatment program for young Israeli [2] military veterans. In: El-Guebaly, N, Carr\u00e0, G, Galanter, M, editors. Textbook of Addiction Treatment: International Perspectives. Springer Milan Heidelberg New York Dordrecht London; 2015. p. 2005\u20132011.","DOI":"10.1007\/978-88-470-5322-9_93"},{"key":"343_CR70","doi-asserted-by":"crossref","unstructured":"Pollack, H. A. (2018). Harm reduction when it\u2019s for our own kids: comment on Hagit Bonny-Noach,\u201cThe evolution of Israeli public policy for drug-using backpackers\". Israel J Health Policy Res, 7(1), 65.","DOI":"10.1186\/s13584-018-0253-9"},{"key":"343_CR71","unstructured":"ELEM, Annual Report, 2017 (p- 7). Retrieved March 2018 from: \n                    https:\/\/www.elem.org.il\/wp-content\/uploads\/2018\/06\/%D7%93%D7%95%D7%97-2017-%D7%91%D7%90%D7%A0%D7%92%D7%9C%D7%99%D7%AA.pdf"},{"key":"343_CR72","unstructured":"Health in all policies: Helsinki statement. Framework for country action. WHO- World Health Organization, 2014. Retrieved March 2018 from: \n                    https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/112636\/9789241506908_eng.pdf;jsessionid=766410585B14F221165C9DE5A5F6790F?sequence=1"},{"key":"343_CR73","unstructured":"PEPFAR -U.S. President\u2019s emergency plan for AIDS relief. Comprehensive HIV Prevention for People Who Inject Drugs, Revised Guidance.2010. Retrieved June 2018 from: \n                    https:\/\/www.pepfar.gov\/documents\/organization\/144970.pdf"},{"key":"343_CR74","unstructured":"MOLSA Annual report, 2017. Internal document."}],"container-title":["Israel Journal of Health Policy Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13584-019-0343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13584-019-0343-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13584-019-0343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T23:27:36Z","timestamp":1602718056000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijhpr.biomedcentral.com\/articles\/10.1186\/s13584-019-0343-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["343"],"URL":"https:\/\/doi.org\/10.1186\/s13584-019-0343-3","relation":{},"ISSN":["2045-4015"],"issn-type":[{"value":"2045-4015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,16]]},"assertion":[{"value":"13 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares that she has no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}